Neurology: Epilepsy, and Alzheimer’s Disease Clinical Trials

California Pacific Epilepsy Program
Comprehensive Stroke Care


Cognitive Decline  |  Seizure Disorders/Epilepsy

Cognitive Decline

Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
Principal Investigator:
Catherine Madison, MD


Contact:
Thais Zayas-Bazan
415-600-5764		Predicition of Cognitive Decline with MRI and MRSISubjects 60 years of age or older who have mild problems with their memory and are comfortable undergoing MRI; healthy volunteers are also neededOpen


Back to top

Seizure Disorders/Epilepsy

Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
Principal Investigator:
Kenneth Laxer, MD

Contact:
Hamid Emamekhoo
415-600-1475		 Neuroimaging In Epilepsy: Additional Neuropsychological Testing Male and Female subjects, age 18-60 years of age, unresponsive to medical treatment for temporal lobe and neocortical epilepsyOpen
Principal Investigator:
David King-Stephens, MD

Contact:
Douglas Raggett
415-600-3777		 RNS™ System Long-term Treatment Clinical Investigation. Subjects with Epilepsy who have completed the RNS™ System Pivotal TrialOpen
Principal Investigator:
David King-Stephens, MD

Contact:
Douglas Raggett
415-600-3777		A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
Eisai E2007-G000-304		Subjects with refractory partial seizuresOpen
Principal Investigator:
David King-Stephens, MD

Contact:
Douglas Raggett
415-600-3777		An Open-Label Extension Phase of the Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Studies to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
E2007-G000-307 		Subjects With Refractory Partial SeizuresOpen


last updated: 3/9/2010
Back to top